Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review

Coronavirus disease-2019 (COVID-19) is associated with systemic inflammation, endothelial activation, and multiorgan manifestations. Lipid-modulating agents may be useful in treating patients with COVID-19. These agents may inhibit viral entry by lipid raft disruption or ameliorate the inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Talasaz, Azita H., Sadeghipour, Parham, Aghakouchakzadeh, Maryam, Dreyfus, Isaac, Kakavand, Hessam, Ariannejad, Hamid, Gupta, Aakriti, Madhavan, Mahesh V., Van Tassell, Benjamin W., Jimenez, David, Monreal, Manuel, Vaduganathan, Muthiah, Fanikos, John, Dixon, Dave L., Piazza, Gregory, Parikh, Sahil A., Bhatt, Deepak L., Lip, Gregory Y.H., Stone, Gregg W., Krumholz, Harlan M., Libby, Peter, Goldhaber, Samuel Z., Bikdeli, Behnood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American College of Cardiology Foundation. Published by Elsevier. 2021
Materias:
The Present and Future
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504484/
https://www.ncbi.nlm.nih.gov/pubmed/34649702
http://dx.doi.org/10.1016/j.jacc.2021.08.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504484/
https://www.ncbi.nlm.nih.gov/pubmed/34649702
http://dx.doi.org/10.1016/j.jacc.2021.08.021

Ejemplares similares